Paclitaxel plus bevacizumab for metastatic breast cancer

N Engl J Med. 2008 Apr 10;358(15):1637; author reply 1637-8.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bevacizumab
  • Bias
  • Breast Neoplasms / drug therapy*
  • Disease Progression
  • Humans
  • Paclitaxel / therapeutic use*
  • Research Design

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Paclitaxel